Trial Profile
Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Carbamazepine; Lithium; Valproic acid
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Acronyms BMAC
- Sponsors Eli Lilly and Company
- 09 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2008 Checked against the ClinicalTrials.gov record.
- 28 Sep 2008 Planned number of patients is now 143 according to the ClinicalTrials.gov record.